H

Hoth Therapeutics
D

HOTH

1.06000
USD
-0.02
(-1.85%)
مغلق
حجم التداول
5,530
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
13,936,612
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ARGX
    -2.16
    (-0.33%)
    645.20 USD
    A
    ARWR
    -1.040
    (-4.97%)
    19.900 USD
    A
    AXON
    -28.72
    (-5.30%)
    513.31 USD
    BIIB
    BIIB
    3.560
    (2.60%)
    140.630 USD
    MELI
    MELI
    142.15
    (6.71%)
    2,259.35 USD
    R
    RCKT
    -0.390
    (-3.59%)
    10.470 USD
    S
    SAVA
    -0.15000
    (-5.56%)
    2.55000 USD
    T
    TTWO
    -3.520
    (-1.64%)
    211.700 USD
    المزيد
الأخبار
المقالات

العنوان: Hoth Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.